Inventor

Celeste Natalie ALVEREZ

Inventor

Overview

2→

Patents

2022–2026

Patent span

Human necessities

Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%

C07DHeterocyclic compounds50%

PatentTitleYear

12,559,480Methods of treatment using phenyl indole allosteric inhibitors of P97 ATPase2026 11,247,985Phenyl indole allosteric inhibitors of P97 ATPase2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to UNIV CALIFORNIA (2)· patent assignee history

2022–2026Patents assigned to UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (2)· patent assignee history

2022Patents assigned to NAT INSTITUTES OF HEALTH A COMPONENT OF THE U S DEPARTMENT OF HEARTH AND HUMAN SERVICES (1)· patent assignee history

2022Patents assigned to NAT INSTITUTES OF HEALTH A COMPONENT OF THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES (1)· patent assignee history

2022–2026Based in US· patent location history

2026Patents assigned to US HEALTH (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV CALIFORNIA	2	2022–2026
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	2	2022–2026
NAT INSTITUTES OF HEALTH A COMPONENT OF THE U S DEPARTMENT OF HEARTH AND HUMAN SERVICES	1	2022
NAT INSTITUTES OF HEALTH A COMPONENT OF THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES	1	2022
US HEALTH	1	2026

Locations

Location	Patents	Span
US	2	2022–2026